CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis
Biomolecules · 30.11.2024 · 14 (12) · 1541
DOI: 10.3390/biom14121541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.11.2024. Verfasst von Andrew R Pachner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. Hauptthemen laut MEDLINE: Chemokine CXCL13, Multiple Sclerosis, Biomarkers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bornstein Research Fund.
Abstract (Originalsprache)
CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ectopic lymphoid follicles. Also reviewed are its utility in multiple sclerosis and Lyme neuroborreliosis and potential problems in its measurement. CXCL13 has the potential to be an exceptionally useful biomarker in a range of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
ORCID-Profile: Steven Pike
Förderung
- Bornstein Research Fund
Zitieren
APA
Pachner, A. R., Pike, S., Smith, A. D., & Gilli, F. (2024). CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis. Biomolecules, 14(12), 1541. https://doi.org/10.3390/biom14121541
Vancouver
Pachner AR, Pike S, Smith AD, Gilli F. CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis. Biomolecules. 2024;14(12):1541. doi:10.3390/biom14121541
BibTeX
@article{Pachner2024,
author = {Pachner, Andrew R and Pike, Steven and Smith, Andrew D and Gilli, Francesca},
title = {CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {12},
pages = {1541},
doi = {10.3390/biom14121541}
}
EUVIMED